SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-040240
Filing Date
2015-05-07
Accepted
2015-05-07 20:05:36
Documents
1
Period of Report
2015-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4148
  Complete submission text file 0001209191-15-040240.txt   5833
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Reporting) CIK: 0000886163 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37355 | Film No.: 15843679
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037
Business Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037 858-550-7810
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations